Trinity Biotech director reports ADS option holdings
TRINITY BIOTECH PLC director John Gillard filed an initial statement of beneficial ownership, showing holdings of ADS options and common ADS.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
TRINITY BIOTECH PLC director John Gillard filed an initial statement of beneficial ownership, showing holdings of ADS options and common ADS. The filing lists multiple option grants over TRIB ADS with exercise prices between $2.40 and $13.45, plus 10,000 ADS held directly.
Insider Trade Summary
31 transactions reported
Mixed
31 txns
Insider
Gillard John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS OPTIONS | -- | -- | -- |
| holding | ADS | -- | -- | -- |
Holdings After Transaction:
ADS OPTIONS — 970,837 contracts (Direct);
ADS — 10,000 shares (Direct)
Key Figures
Direct ADS held: 10,000 ADS
Option block at $13.45: 7,500 underlying ADS
Option block at $5.70: 40,000 underlying ADS
+3 more
6 metrics
Direct ADS held
10,000 ADS
Direct ownership reported on Form 3
Option block at $13.45
7,500 underlying ADS
ADS options, exercise price $13.45, expiring October 23, 2027
Option block at $5.70
40,000 underlying ADS
ADS options, exercise price $5.70, expiring December 19, 2029
Option block at $5.45
35,000 underlying ADS
ADS options, exercise price $5.45, expiring March 25, 2029
Option block at $2.40 (11 Dec)
43,750 underlying ADS
ADS options, exercise price $2.40, expiring December 11, 2030
Option block at $2.40 (19 Dec)
29,167 underlying ADS
ADS options, exercise price $2.40, expiring December 19, 2030
Key Terms
ADS OPTIONS, ADS, Form 3, beneficial ownership
4 terms
ADS OPTIONS financial
"The filing lists holdings of ADS OPTIONS with various exercise prices."
ADS financial
"Gillard also reports 10,000 ADS held directly."
Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.
Form 3 regulatory
"This Form 3 is an initial statement of beneficial ownership."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"Form 3 provides an initial statement of beneficial ownership."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does John Gillard’s Form 3 for TRINITY BIOTECH PLC (TRIB) show?
The Form 3 shows John Gillard’s initial beneficial ownership in Trinity Biotech. It lists several ADS option positions at different exercise prices and expiration dates, plus 10,000 American Depositary Shares (ADS) held directly as of the reported date.
How many TRINITY BIOTECH (TRIB) ADS does John Gillard hold directly?
John Gillard reports direct ownership of 10,000 ADS. These are American Depositary Shares of Trinity Biotech held outright, separate from his ADS option awards, which give the right to acquire additional ADS at set exercise prices in future.
What ADS option positions does John Gillard report for TRINITY BIOTECH (TRIB)?
He reports multiple ADS option grants, including blocks with exercise prices of $13.45, $5.70, $5.45 and $2.40. Each grant covers tens of thousands of underlying ADS and has stated expiration dates between 2027 and 2030.
What are the key exercise prices and expirations in Gillard’s TRIB ADS options?
Reported ADS options include exercise prices of $13.45 expiring on October 23, 2027, $5.70 expiring on December 19, 2029, $5.45 expiring on March 25, 2029, and $2.40 expiring on dates through 2030.
Is John Gillard’s ownership in TRINITY BIOTECH (TRIB) direct or indirect?
The filing classifies all reported positions as direct ownership. Both the ADS and ADS options show ownership code “D” for direct, with no nature-of-ownership footnotes describing trusts, partnerships, or other indirect holding structures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates